These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18929009)

  • 1. An accurate and precise high-performance liquid chromatography method for the rapid quantification of the novel HIV integrase inhibitor raltegravir in human blood plasma after solid phase extraction.
    Rezk NL; White N; Kashuba AD
    Anal Chim Acta; 2008 Nov; 628(2):204-13. PubMed ID: 18929009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
    Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
    J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of the HIV-integrase inhibitor raltegravir (MK-0518) in human plasma by high-performance liquid chromatography with fluorescence detection.
    Poirier JM; Robidou P; Jaillon P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(2):277-81. PubMed ID: 18434263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive HPLC-MS-MS method for the determination of raltegravir in human plasma.
    Long MC; Bennetto-Hood C; Acosta EP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(2):165-71. PubMed ID: 18430616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of raltegravir (MK0518) in human plasma by high-performance liquid chromatography with photodiode array detection.
    Goldwirt L; Barrail-Tran A; Da Cruz M; Taburet AM; Furlan V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):456-60. PubMed ID: 19962949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid-liquid extraction and HPLC-MS/MS.
    Merschman SA; Vallano PT; Wenning LA; Matuszewski BK; Woolf EJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):15-24. PubMed ID: 17644453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients.
    D'Avolio A; Baietto L; Siccardi M; Sciandra M; Simiele M; Oddone V; Bonora S; Di Perri G
    Ther Drug Monit; 2008 Dec; 30(6):662-9. PubMed ID: 18824956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ultrasensitive LC-MS/MS assay for quantification of intracellular raltegravir in human cell extracts.
    Robbins BL; Nelson SR; Fletcher CV
    J Pharm Biomed Anal; 2012 Nov; 70():378-87. PubMed ID: 22727807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conventional LC-MS method developed for the determination of plasma raltegravir concentrations.
    Takahashi M; Konishi M; Kudaka Y; Okumura N; Hirano A; Terahata N; Banno K; Kaneda T
    Biol Pharm Bull; 2008 Aug; 31(8):1601-4. PubMed ID: 18670096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
    Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
    Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive liquid chromatography coupled with mass spectrometry method for the intracellular and plasma quantification of raltegravir after solid-phase extraction.
    Mosnier-Thoumas S; Djabarouti S; Xuereb F; Lazaro E; Pellegrin JL; Saux MC; Breilh D
    J Pharm Pharmacol; 2011 Dec; 63(12):1559-65. PubMed ID: 22060286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the HIV-1 integrase inhibitor raltegravir in female genital tract secretions using high-performance liquid chromatography with ultraviolet detection.
    Talameh JA; Rezk NL; Kashuba AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):92-6. PubMed ID: 19942487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction.
    Rezk NL; Crutchley RD; Kashuba AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):201-8. PubMed ID: 16005269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
    D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Oddone V; Stefani FR; Agati S; Cusato J; Bonora S; Di Perri G
    J Pharm Biomed Anal; 2011 Mar; 54(4):779-88. PubMed ID: 21071165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma.
    Rezk NL; Tidwell RR; Kashuba AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):241-7. PubMed ID: 15135096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatography method for the quantification of rabeprazole in human plasma using solid-phase extraction.
    Ramakrishna NV; Vishwottam KN; Wishu S; Koteshwara M; Kumar SS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):209-14. PubMed ID: 15664352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of tenofovir in human plasma by solid-phase extraction and high-performance liquid chromatography coupled with UV detection.
    Kou H; Du X; Li Y; Fu Q; Zhu Z; Li T
    Ther Drug Monit; 2012 Oct; 34(5):593-8. PubMed ID: 22960734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of specificity for the analysis of raltegravir using online sample clean-up liquid chromatography-electrospray tandem mass spectrometry.
    Jourdil JF; Bartoli M; Stanke-Labesque F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3734-8. PubMed ID: 19744899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography-tandem mass spectrometric method.
    Wang LZ; Lee LS; Thuya WL; Soon GH; Kong LR; Nye PL; Lee EJ; Flexner C; Goh BC
    J Mass Spectrom; 2011 Feb; 46(2):202-8. PubMed ID: 21259392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid validated UV-HPLC method for the simultaneous determination of the antiretroviral compounds darunavir and raltegravir in their dosage form.
    Estan-Cerezo G; García-Monsalve A; Soriano-Irigaray L; Rodríguez-Lucena FJ; Navarro-Ruiz A
    Rev Esp Quimioter; 2017 Jun; 30(3):195-200. PubMed ID: 28361525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.